Milder phenotypes of glucose transporter type 1 deficiency syndrome
Article first published online: 24 MAR 2011
© The Authors. Developmental Medicine & Child Neurology © 2011 Mac Keith Press
Developmental Medicine & Child Neurology
Volume 53, Issue 7, pages 664–668, July 2011
How to Cite
ANAND, G., PADENIYA, A., HANRAHAN, D., SCHEFFER, H., ZAIWALLA, Z., COX, D., MANN, N., HEWERTSON, J., PRICE, S., NEMETH, A., ARSOV, T., SCHEFFER, I., JAYAWANT, S., PIKE, M. and MCSHANE, T. (2011), Milder phenotypes of glucose transporter type 1 deficiency syndrome. Developmental Medicine & Child Neurology, 53: 664–668. doi: 10.1111/j.1469-8749.2011.03949.x
- Issue published online: 7 JUN 2011
- Article first published online: 24 MAR 2011
- PUBLICATION DATA Accepted for publication 1st February 2011 Published online 24th March 2011.
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a treatable condition resulting from impaired glucose transport into the brain. The classical presentation is with infantile-onset epilepsy and severe developmental delay. Non-classical phenotypes with movement disorders and early-onset absence epilepsy are increasingly recognized and the clinical spectrum is expanding. The hallmark is hypoglycorrhachia (cerebrospinal fluid [CSF] glucose<2.2mmol/l) in the presence of normoglycaemia with a CSF/blood glucose ratio of less than 0.4. GLUT1DS is due to a mutation in the solute carrier family 2, member 1 gene (SLC2A1). We present five individuals (four males, one female), all of whom had a mild phenotype, highlighting the importance of considering this diagnosis in unexplained neurological disorders associated with mild learning difficulties, subtle motor delay, early-onset absence epilepsy, fluctuating gait disorders, and/or dystonia. The mean age at diagnosis was 8 years 8 months. This paper also shows phenotypical parallels between GLUT1DS and paroxysmal exertion-induced dyskinesia.